China is looking to place limits on the amount of products infant formula companies can sell in the country.

Two options are set out under regulations drafted by Beijing. Under the first, companies would be limited to selling a maximum of 15 brands.

The second option means manufacturers would have to prove infant formula made for a specific age group had "significant differences" with other lines and contained at least six different ingredients.

The legislation, which is open for public comment until 1 October, also states manufacturers will have to re-register their infant formula recipes with the China Food and Drug Administration.

Torsten Stocker, a partner at AT Kearney, said the proposed measures were part of a series of moves recently introduced in China to "create a sector with fewer, stronger players that provide safe choices to consumers, while at the same time boosting breastfeeding rates".

Stocker said China last year started to limit the number of infant formula brands that could enter the market and stopped renewing licences for some smaller, domestic manufacturers. More recently, Beijing drafted amendments to advertising laws that ban claims to the effect infant formula can replace breastfeeding.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

"Now it is limiting the number of products, and requiring that they be distinct in terms of ingredients and benefits – although what that means may be open to interpretation – creating more transparency for consumers and limiting how brands can compete, especially those that don't have any real differentiation," Stocker said.